Yahoo! Finance: Top Stories

Why Novo missed its sales estimates on weight-loss drug Wegovy: CEO

May 7, 2025 - 17:57
 0
Why Novo missed its sales estimates on weight-loss drug Wegovy: CEO
Read More

Tags:

Previous Article

J&J Medtech survey finds strong European support for healthcare data sharing

Next Article

Jim Cramer on Microsoft Corporation’s (MSFT) Earnings Report: ‘Happy Call’

Related Posts

Advanced Micro Devices, Inc. (AMD) Is a Good Buy on Weakness, Commentator Suggests

Advanced Micro Devices, Inc. (AMD) Is a Good Buy on Wea...

May 6, 2025  0

Madison Square Garden Sports Corp. (MSGS): Among Top Stocks in Bill Gates’ Portfolio with Huge Upside Potential

Madison Square Garden Sports Corp. (MSGS): Among Top St...

Apr 23, 2025  0

Skeena Resources Limited (SKE): Among the Best Precious Metals Stocks to Buy According to Analysts

Skeena Resources Limited (SKE): Among the Best Precious...

Apr 25, 2025  0